Hundreds of people who sued Pfizer alleging birth defects from its antidepressant Zoloft will be allowed to present another expert after the first one they offered to the court was tossed last summer.
U.S. District Judge Cynthia Rufe of the Eastern District of Pennsylvania, who is handling the multidistrict litigation case, decided to allow the plaintiffs a second try in offering a key expert to testify as to Zoloft’s causation of birth defects in babies born to mothers who took the drug while pregnant. Her decision came over the strong objections of Pfizer, which might have prevailed in barring the submission of a new expert in a less complex trial.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
